Bca of Detroit, LLC
Bca of Detroit, LLC was paid $995K by Medicaid between Jan 2018 and Dec 2019, across 77 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 69% of everything it billed.
DETROIT, MI 48205
Next to other Multi-Specialty Clinic/Center providers in Michigan
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 293 | $0.00 | |
| 2019 | 80,556 | $995K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 69% | 9,793 | 8,166 | $684K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 12% | 6,702 | 5,814 | $117K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.2% | 5,024 | 5,014 | $32K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 6,136 | 6,075 | $22K |
| 80061 | Lipid panel | 1.9% | 6,489 | 6,470 | $19K |
| 80053 | Comprehensive metabolic panel | 1.6% | 6,636 | 6,593 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 7,344 | 7,172 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.2% | 5,660 | 5,641 | $12K |
| 82607 | <1% | 3,147 | 3,139 | $9K | |
| 84439 | <1% | 4,042 | 4,016 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 78 | 78 | $7K |
| 80074 | <1% | 649 | 648 | $6K |
65 more codes
| 80305 | <1% | 1,375 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 458 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 416 | $4K |
| 84480 | <1% | 567 | $3K | |
| 84481 | <1% | 520 | $3K | |
| 84153 | <1% | 567 | $2K | |
| 82746 | <1% | 452 | $2K | |
| 86235 | <1% | 102 | $2K | |
| 82728 | <1% | 440 | $2K | |
| 84436 | <1% | 729 | $2K | |
| 83735 | <1% | 743 | $1K | |
| 87536 | <1% | 46 | $1K | |
| 84403 | <1% | 168 | $1K | |
| 87088 | <1% | 479 | $1K | |
| 84550 | <1% | 1,043 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 462 | $1K |
| 86703 | <1% | 396 | $978.33 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 16 | $909.60 |
| 84479 | <1% | 501 | $837.32 | |
| 86696 | <1% | 146 | $821.62 | |
| 84402 | <1% | 145 | $783.20 | |
| 80164 | <1% | 206 | $762.52 | |
| 84146 | <1% | 171 | $737.88 | |
| 82043 | <1% | 747 | $714.04 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 316 | $695.46 |
| 83540 | <1% | 389 | $657.83 | |
| 83550 | <1% | 272 | $654.62 | |
| 87581 | <1% | 78 | $610.01 | |
| 87486 | <1% | 78 | $610.01 | |
| 86695 | <1% | 144 | $559.54 | |
| 86803 | <1% | 114 | $527.52 | |
| 86701 | <1% | 217 | $477.90 | |
| 85651 | <1% | 497 | $456.90 | |
| 81000 | <1% | 533 | $449.35 | |
| 86141 | <1% | 134 | $436.16 | |
| 82248 | <1% | 288 | $366.31 | |
| 87070 | <1% | 202 | $332.45 | |
| 85027 | <1% | 155 | $328.24 | |
| 86592 | <1% | 267 | $325.67 | |
| 86038 | <1% | 121 | $320.73 | |
| 82570 | <1% | 348 | $287.18 | |
| 86225 | <1% | 103 | $279.10 | |
| 83001 | <1% | 85 | $258.40 | |
| 83655 | <1% | 117 | $252.72 | |
| 81003 | <1% | 349 | $201.44 | |
| 85610 | <1% | 187 | $176.47 | |
| 86430 | <1% | 136 | $172.33 | |
| 83002 | <1% | 48 | $149.05 | |
| 86431 | <1% | 133 | $148.60 | |
| 80076 | <1% | 83 | $130.19 | |
| 80178 | <1% | 93 | $124.65 | |
| 87077 | <1% | 64 | $122.45 | |
| 82540 | <1% | 98 | $102.92 | |
| 85007 | <1% | 113 | $96.06 | |
| 80051 | <1% | 78 | $92.43 | |
| 82565 | <1% | 82 | $84.48 | |
| 84703 | <1% | 43 | $75.65 | |
| 86593 | <1% | 80 | $72.40 | |
| 84520 | <1% | 89 | $67.28 | |
| 84154 | <1% | 12 | $53.88 | |
| 84466 | <1% | 15 | $46.70 | |
| 82670 | <1% | 12 | $40.88 | |
| 82550 | <1% | 16 | $38.08 | |
| 83690 | <1% | 12 | $5.04 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,053 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Galax Treatment Center, LLC | Galax, VA | $164.22M |
| White Deer Run, LLC | Allenwood, PA | $145.83M |
| Bgi of Brandywine, LLC | Kennett Square, PA | $54.55M |
| CRC Health Oregon, LLC | Portland, OR | $27.60M |
| Discovery House of Central Maine, INC. | Waterville, ME | $24.46M |
| CRC Health Oregon, LLC | Portland, OR | $24.34M |
| Center for Behavioral Health-Pa, LLC | Cranberry Township, PA | $23.46M |
| R.I.S.A.T., LLC | Woonsocket, RI | $21.60M |
| Center for Behavioral Health Me, INC. | South Portland, ME | $20.08M |
| CRC Health Oregon, LLC | Portland, OR | $17.15M |
| Richmond Treatment Center, LLC | Richmond, IN | $16.79M |
| CRC Health Oregon, LLC | Tigard, OR | $14.32M |
| Center for Behavioral Health Ha, LLC | Harrisburg, PA | $14.30M |
| R.I.S.A.T., LLC | Providence, RI | $14.02M |
| Evansville Treatment Center, LLC | Evansville, IN | $13.53M |
| Ats of Cecil County, INC. | Lavale, MD | $11.86M |
| Advanced Treatment Systems, LLC | Lebanon, PA | $11.77M |
| Milwaukee Health Services System, LLC | Milwaukee, WI | $11.32M |
| Milwaukee Health Services System, LLC | Madison, WI | $10.89M |
| PHC of Virginia, LLC | Salem, VA | $10.62M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.